TABLE 2

Measurement properties of the tests reviewed

Main variablesPractice test neededStandardisationMCIDReproducibility
IETVO2peak, WRpeak and VE–VCO2 indicesNoAdjusting WR increments to the patient capacity
Criteria for “good effort”
No
Suggested targets in PAH:
VO2 >10 L·min−1·kg−1
VE–VCO2 slope <45
VO2peak 5–10%
WRpeak 5–10%
VE–VCO2 indices ±2.3 both within and between individuals
CWRETtLIM, isotime IC and isotime dyspnoeaNoIntensity of baseline tests to attain tLIM between 180 and 480 s recommended to reduce variability
Pedalling rate
Criteria to terminate the test
105 s or 33%
Bronchodilator trials suggest that clinical outcomes improve with increases >60 s
tLIM: 5–10% within individuals
23.7% between individuals
ISWTTime/distance, dysponea and SpO2YesAudio signal47 mNA
ESWTTime/distance, dyspnoea and SpO2YesAudio signal
Optimum intensity/duration of baseline test yet to be defined
Time 56–71 s Distance 72–81 mTime −7±72 s
Distance −7±113 m
both within individuals
6MWTDistance/SpO2 and dyspnoeaYesTrack length
Encouragement
25–33 m
In PAH, MCID relates to symptom amelioration, but not to survival
Distance 5–8% when performed twice
within individuals
  • MCID: minimal clinically important difference; IET: incremental exercise test; CWRET: constant work-rate exercise test; ISWT: incremental shuttle walk test; ESWT: endurance shuttle walk test; 6MWT: standardised 6-min walk test; VO2peak: peak oxygen uptake; WRpeak: peak work-rate (or peak power); VE–VCO2: ventilation–carbon dioxide output indices; WR: work-rate; PAH: pulmonary arterial hypertension; VO2: oxygen uptake; tLIM: tme to the limit of tolerance, typically for constant work-rate tests; IC: inspiratory capacity; SpO2: arterial blood oxygen saturation measured by pulse oximetry; NA: not applicable.